Angioimmunoblastic T-cell lymphoma (AITL) is considered to originate from follicular helper T (TFH) cells. Currently, neoplastic cells in AITL are considered to express CXCL13 as a tumor marker. However, the identification of CXCL13 + cells remains unclear in terms of whether they are neoplastic cells (or TFH cells) or follicular dendritic cells (FDCs) in both AITL and normal germinal centers. Therefore, the exact identification of CXCL13 + cells was performed using 33 cases of AITL and normal germinal centers. Single-labeling immunohistochemistry and double-labeling immunofluorescent microscopy first confirmed that CXCL13 was expressed mainly in FDCs in the normal germinal centers. In 28 of 33 AITL cases, CXCL13 was expressed mainly in FDCs as a meshwork pattern, which was associated with CXCL13 + neoplastic cells. In the other five cases, CXCL13 was expressed mainly in neoplastic cells, which were densely distributed in and around the FDC meshwork. 
INTRODUCTION
Angioimmunoblastic T-cell lymphoma (AITL) is a unique peripheral T-cell lymphoma (PTCL) composed of the proliferation of not only neoplastic T cells but also various reactive host cells including high endothelial venules (HEVs), B cells often with a blast form, plasma cells, and follicular dendritic cells (FDCs) that form a disorganized meshwork structure (hereinafter called the FDC meshwork in AITL). [1] [2] [3] Of these, the proliferation of both FDCs and HEVs distinguishes AITL from other PTCLs. 4 PTCLs that lack either the proliferation of FDCs or that of HEVs are designated AITL-like PTCLs in the present paper. AITL is currently considered to originate from follicular helper T (TFH) cells. [5] [6] [7] TFH cells belong to a subset of CD4 + T cells. After antigen stimulation, CD4 + naïve T cells differentiate into T helper type 1 (TH1), type 2 (TH2), interleukin (IL)-17-producing helper T (TH17) cells, inducible regulatory T (iTReg) cells, or TFH cells. 8, 9 Of these, TFH cells are defined as CD4 + T cells that express chemokine C-X-C motif receptor 5 (CXCR5), inducible T-cell costimulator (ICOS), programmed cell death protein 1 (PD1), B-cell lymphoma 6 (BCL-6), and IL-21. 8, 9 In AITL, chemokine CXCL13 is considered to be a tumor marker. 1, 10, 11 CXCL13, together with its cognate receptor CXCR5 (i. e., the CXL13-CXCR5 axis), plays an essential role in the formation of germinal centers in the secondary lymphoid organs. 12, 13 FDCs in such lymphoid organs express CXCL13. [14] [15] [16] [17] FDCs form a well-organized meshwork in the light zone of germinal centers and express antigen-antibody complex on their cell surface, thereby mediating the positive selection of B cells with high-affinity antibodies. 16, 17 FDCs secrete CXCL13 to chemo-attract CXCR5 + follicular B cells and CXCR5 + TFH cells. Agostinelli et al. described that CXCL13 was also expressed in FDCs in AITL. 4 Considering this complicated situation, the present study revisited CXCL13 to perform the exact cell identification of CXCL13 + cells in AITL in comparison to normal germinal centers. We show here that CXCL13 is expressed mainly in FDCs and also in neoplastic T cells, and that the FDC meshwork in AITL harbors neoplastic cells and B cells. CXCR5, counterreceptor of CXCL13, is expressed by neoplastic cells. We discuss the possible significance of these findings in relation to the histogenesis of AITL.
MATERIALS AND METHODS
Formalin-fixed, paraffin-embedded tissue samples were used. In all lymphoma cases, tissue samples were obtained at the initial diagnosis, including 33 cases of AITL (mean age 67.4 ± 13.3 years, males: females (M:F) = 18:15) and six cases of AITL-like PTCL (mean age 69.8 ± 10.1 years, M:F = 3:3). 4 All lymphoma cases were of nodal type. The diagnosis of AITL was performed as described by the WHO classification.
1 All AITL-like PTCLs in the present study showed less developed HEVs than AITL, retaining the FDC meshwork.
For the normal controls, both secondary lymphoid organs and tertiary lymphoid tissues were used. The secondary lymphoid organs (18 cases, mean age 46.8 ± 22.1 years, M:F = 10:8) included seven cases of chronic tonsillitis and 11 cases of reactive hyperplasia of the lymph nodes. Tertiary lymphoid tissues (12 cases, mean age 67.4 ± 11.6 years, M:F = 8: 4) included four cases of chronic cholecystitis, two cases of nodular lymphoid hyperplasia of the lung, and one case each of chronic urocystitis, chronic thyroiditis, inflammatory pseudotumor of the lung, chronic sclerosing sialoadenitis, chronic esophagitis, and diverticulitis. These control tissues were obtained by surgical resection.
For conventional immunohistochemistry, the second-step immunoperoxidase method was used as described previously. 18 Antigen retrieval was performed by immersing glass slides in 10 mM Tris buffer/1 mM EDTA at 95℃ for 60 min. For CD21 immunostaining, DAKO S-1700 was used for antigen retrieval. After the blocking of non-specific reactivity by Protein Block (DAKO, Glostrup, Denmark), primary antibodies were applied (Table 1) . After quenching the endogenous peroxidase activity with 3% H2O2 for 5 min, Envision plus (DAKO) was applied as a secondary antibody. 3, 3'-Diaminobenzidine tetrahydrochloride was used as a chromogen.
For immunofluorescent staining, all of the primary antibodies were applied overnight. Alexa Fluor (350, 488, or 555)-labeled anti-mouse, rabbit, or goat immunoglobulin antibodies (raised in donkey) were used as the secondary antibodies (diluted at 1:100, applied for 30 min) (Molecular Probes; Thermo Fisher Scientific Inc., Waltham, MA, USA). For the double-or triple-immunofluorescent method, two or three different kinds of primary or secondary antibodies were applied in a mixture. 4',6-Diamidino-2-phenylindole (Molecular Probes) was used for nuclear counterstaining. All of the fluorescent images were captured using a digital camera (DS-5M; Nikon, Tokyo, Japan) equipped on a fluorescent microscope (E800; Nikon). For double-and triple-immunofluorescent microscopy, each fluorescent image was manually merged on a computer using PaintShop Photo Pro X3 (Corel, Ottawa, Canada). Detailed analyses of the fluorescent images were performed by confocal laser scanning microscopy (Leica SP5; Wetzlar, Germany).
For the negative control, isotype-matched, control mouse monoclonal antibodies (DAKO) or normal rabbit or goat immunoglobulins were used. These control staining samples showed no significant immunoreactivity.
The present study was approved by the ethics committees of the institutes from which the materials were obtained. 
RESULTS

Identification of CXCL13 + cells as mainly FDCs and partly TFH cells in the normal lymphoid tissues
Previous reports described that CXCL13 was localized in either TFH cells 10, 11 or FDCs [14] [15] [16] [17] in the normal lymphoid tissues. Single-labeling immunohistochemistry showed that CXCL13 was expressed as a characteristic meshwork pattern in the light zone of germinal centers in all cases except one (vide infra for details). Double-immunofluorescent microscopy clearly showed the co-localization of CXCL13 and FDC markers (Fig. 1A) , indicating that CXCL13 was mainly expressed in FDCs. The co-expression of CXCL13 and CD3 (or CD4) was observed infrequently in the germinal centers (Fig. 1B) . Since TFH cells are a major component of follicular T-cells, 19 this indicated the infrequent occurrence of CXCL13 + TFH cells. The exception was one case of tertiary lymphoid tissues (chronic thyroiditis), in which CXCL13 was expressed mainly in lymphocytes. CD83 + dendritic cells (DCs) (conventional or classical DCs) in the paracortex also expressed CXCL13 (Supplementary data).
CXCL13 is expressed mainly in FDCs and to various degrees in neoplastic cells in AITL
Of 33 cases of AITL, 32 were of the "classical type" (pattern 2 or 3), and one belonged to pattern 1.
1 Singlelabeling immunohistochemistry revealed that CXCL13 was expressed in either a meshwork ( Fig. 2A) or a perinuclear dot pattern (Fig. 2B) . In 23 of 33 AITL cases, doubleimmunofluorescent microscopy was performed, which revealed the following findings. In areas with a meshwork pattern, co-localization of CXCL13 and FDC markers was observed (Fig. 2C) , confirming that FDCs expressed CXCL13. This also showed a similarity between the FDC meshwork in AITL (Fig. 2C ) and the normal germinal center (Fig. 1A) . In areas with a perinuclear dot pattern, colocalization of CXCL13 and CD3 (or CD4) was demonstrated (Fig. 2D) , indicating that CXCL13 is expressed in neoplastic cells. Combining the results of single-and double-labeling data, we judged that CXCL13 + cells were mainly FDCs associated with various degrees of CXCL13 + neoplastic cells in 28 of 33 AITL cases (all classical type [pattern 2 or 3]). In the other five cases (including one case with pattern 1), CXCL13 + cells were mainly neoplastic cells without remarkable reactivity in FDCs (note that the FDC meshwork was observed in all cases examined). The FDC meshwork in AITL was usually irregular in shape and larger than the normal germinal centers. 20 The cytoplasmic processes of FDCs may be less intensely labeled with CXCL13, occasionally making them difficult to identify as FDCs. Therefore, care should be taken for the presence of cytoplasmic processes to identify FDCs.
Among six AITL-like PTCL cases, CXCL13 was localized in both FDCs and neoplastic cells in three cases, or mainly in neoplastic cells without significant expression in FDCs in the other three cases (data not shown).
CXCL13
+ cells are concentrated in FDC meshwork irrespective of the cell source
We next focused our attention on five cases of AITL and three cases of AITL-like PTCL in which mainly neoplastic cells expressed CXCL13. Double-labeling immunofluorescent microscopy revealed that CXCL13 + neoplastic cells were abundantly distributed in and around the FDC meshwork in six of eight cases (Fig. 2E) . Therefore, it was clear that CXCL13 + cells were densely concentrated in the FDC meshwork irrespective of the CXCL13 + cell types in AITL and AITL-like PTCL cases.
FDC meshwork in AITL harbors neoplastic cells and B cells
To explore how neoplastic T cells or B cells were distributed among the FDC meshwork in AITL, we conducted triple-labeling immunofluorescent microscopy for CD3, CXCL13, and CD20. In the normal lymphoid tissues (one case of lymph node and four tonsillitis cases), this triplecolor method revealed that both follicular B cells and T cells (mainly TFH cells 19 ) were enmeshed among FDCs in the light zone of the germinal centers (Fig. 3A) . We next analyzed 10 representative AITL cases, in which CXCL13 was expressed mainly in FDCs. Although the structure of the FDC meshwork in AITL differed from that of the normal germinal centers, the same three components (T cells, B cells, and FDCs) were identified in the FDC meshwork in AITL with Tcell dominance (Fig. 3B) .
We next analyzed whether or not neoplastic T cells were included in the FDC meshwork in AITL. Single-labeling immunohistochemistry revealed that the FDC meshwork in AITL harbored neoplastic cells with large, atypical nucleus (Fig. 4A) . The normal germinal centers lacked such atypical cells (Fig. 4B) . Close observation by the triple-color method revealed that both CD3 + neoplastic cells and CD20 + B cells were closely juxtaposed to CXCL13 + FDCs with neoplastic cells as a major component (Fig. 4C) . High-resolution images were obtained by confocal laser scanning microscopy, which showed that neoplastic CD3 + cells with atypical nucleus (shown in green) were in close contact with CXCL13 + FDCs (shown in red) (Fig. 4D) . The data so far indicated that the FDC meshwork in AITL harbored significant numbers of neoplastic T cells as well as B cells. This indicates that the FDC meshwork in AITL retains a similarity to normal germinal centers.
This close contact between neoplastic cells and FDCs in AITL (Fig. 4C & 4D) was unexpected. Therefore, normal germinal centers were analyzed by the same method, where T cells (mainly TFH cells) were again in close contact with FDCs (Fig. 4E ). Our observations suggest certain interactions between FDCs and T cells (for details, see Discussion).
Expression of CXCR5 in AITL
We next analyzed the expression of CXCR5, the cognate receptor of CXCL13. In the normal tissue, CXCR5 is reported to be expressed in follicular B cells and TFH cells. 17 Double-immunofluorescent microscopy in the normal lymphoid follicles showed, therefore, that CXCR5 + cells were specifically distributed in the germinal centers closely associated with CXCL13 + FDCs (Fig. 5A ). This is in accordance with the ligand-receptor relationship. In AITL (20 cases), single-labeling immunohistochemistry revealed that CXCR5 + cells were distributed diffusely in neoplastic tissues (Fig. 5B  & 5C ). Double-immunofluorescent microscopy was performed in five AITL cases and one AITL-like PTCL case, in which CXCL13 was mainly expressed in FDCs. This revealed that CXCR5 + cells were distributed in and around the CXCL13 + FDC meshwork (Fig. 5D ). The data here (Fig. 5A  vs. Fig. 5D ) again indicated a similarity between the FDC meshwork and the normal germinal centers.
DISCUSSION
The present study analyzed AITL from the viewpoint of CXCL13 expression and formation of the FDC meshwork. Since the cell identification in AITL is complicated, multicolor immunofluorescent microscopy was adopted, to reveal the following findings: 1) concentrated expression of CXCL13 in FDC meshwork areas in AITL, 2) similarities between the FDC meshwork in AITL and normal germinal centers, and 3) a close relationship between CXCL13 and its cognate receptor, CXCR5, in both AITL and normal germinal centers. Normal TFH cells play important roles in the formation and maintenance of germinal centers and B-cell differentiation.
9 Therefore, our results based on the analyses of immuno-architecture are consistent with a view that neoplastic cells in AITL retain a certain level of TFH-cell functions.
We first need to discuss the much wider expression of CXCL13 in FDCs than is currently considered and the accumulation of CXCL13 + cells in and around FDC meshwork areas, irrespective of the cell types that express CXCL13. In this sense, some differences are noted between our data and previous observations. 10, 11 As stated in the Results, it is likely that not all FDCs express CXCL13 in the whole cytoplasm, making cytoplasmic processes occasionally less visible. This may cause FDCs to be recognized as tumor cells. This is why we adopted double-immunofluorescent microscopy for the identification of CXCL13 + cells. We next confirmed the presence of a similarity between the FDC meshwork in AITL and the normal germinal centers. In both, FDCs frequently express CXCL13, and both harbored B cells and T cells. The distribution of CXCR5, the cognate receptor of CXCL13, further supports this similarity. This similarity also suggests that the CXCL13-CXCR5 axis may be involved in the formation of the FDC meshwork in AITL, in a similar way as in normal germinal centers. 12, 13 Differences were also noted; for example, in AITL, the FDC meshwork was disorganized structurally, and it harbored abundant neoplastic T cells, contrasted by B-cell dominance in the normal germinal centers. The ubiquitous distribution of CXCR5 + cells in AITL was also different from the concentration of CXCR5 + cells in the normal germinal centers. The similarities between the FDC meshwork in AITL and normal germinal centers described above support the current histogenesis theory, which considers that AITL originates from TFH cells because neoplastic cells may contribute to the formation of the FDC meshwork so as to accumulate B cells in those areas as the normal TFH cells do in the germinal centers. 8, 9 This could explain the proliferation of B cells and plasma cells, as well as polyclonal gammopathy, in AITL. Recent gene expression analyses showed that the participation of B cells in AITL is a favorable prognostic factor. 7, 21 Taking these findings together, it is possible that neoplastic cells in AITL retain a certain level of TFH -cell function. In other words, we may be able to consider that AITL is "a functioning tumor" of TFH cells so as to form the FDC meshwork in tumor tissue.
As expected from its localization in the normal germinal centers, CXCR5 was reported to be expressed in follicular lymphoma, 22 and the host genetic variation in CXCR5 has a role in lymphomagenesis, particularly for follicular lymphoma. 23 A recent study also suggested the possibility of targeting CXCR5 in B-cell non-Hodgkin lymphoma. 24 The close contact between neoplastic T cells (or normal TFH cells) and FDCs suggests a functional relationship between these two cells. It was suggested that TFH cells may require ongoing signals from B cells and FDCs to maintain the TFH program, 9 which may be relevant to the present observations.
Recent studies revealed that hyperplastic follicles in pattern 1 AITL are different from reactive follicles. 25, 26 The relationship between FDCs in these hyperplastic follicles and the FDC meshwork in pattern 2 or 3 will be an important theme of future studies, since detailed analyses were not performed in the present study due to the limited number of cases with pattern 1.
To conclude, the present study clarified the structure of the FDC meshwork in AITL to reveal similarities to normal germinal centers, based on analyses of the immunoarchitecture. The results suggest that AITL could be regarded as "a functioning tumor" of TFH cells. Further analyses will be required.
